The nucleosome (histone-dna complex) is the tlr9-specific immunostimulatory component of plasmodium falciparum that activates dcs

PLoS ONE

Volumn 6, Issue 6, 2011, Pages

  Gowda, Nagaraj M ^a   Wu, Xianzhu ^a   Gowda, D Channe ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; FLT3 LIGAND; GAMMA INTERFERON; HISTONE; INTERLEUKIN 12; MYELOID DIFFERENTIATION FACTOR 88; PROTOZOAL DNA; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; FLT3 LIGAND PROTEIN; MEMBRANE PROTEIN; PROTOZOAL PROTEIN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL DIFFERENTIATION; CELL FRACTIONATION; CELL NUCLEUS; CHROMATIN; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DNA PROTEIN COMPLEX; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; NUCLEOSOME; PLASMODIUM FALCIPARUM; PROTEIN BINDING; WILD TYPE; ANIMAL; BIOSYNTHESIS; CYTOLOGY; IMMUNOLOGY; INFLAMMATION; MEROZOITE; METABOLISM; PARASITOLOGY; SPLEEN; TUMOR CELL LINE;

MUS; PLASMODIUM FALCIPARUM;

ANIMALS; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CYTOKINES; DENDRITIC CELLS; DNA, PROTOZOAN; HISTONES; HUMANS; INFLAMMATION; MEMBRANE PROTEINS; MEROZOITES; MICE; NUCLEOSOMES; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; SPLEEN; TOLL-LIKE RECEPTOR 9;

EID: 79958158236     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0020398     Document Type: Article

References (60)

1. Miller LH, Baruch DI, Marsh K, Doumbo OK, (2002) The pathogenic basis of malaria. Nature 415: 673-679.
2. Augustine AD, Hall BF, Leitner WW, Mo AX, Wali TM, et al. (2009) NIAID workshop on immunity to malaria: Addressing immunological challenges. Nat Immunol 10: 673-678.
3. Snow RW, Guerra CA, Noor AM, Myint HY, Hay SI, (2005) The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434: 214-217.
4. Cox-Singh J, Singh B, (2008) Knowlesi malaria: newly emergent and of public health importance. Trends Parasitol 24: 406-410.
5. Pierce SK, Miller LH, (2009) World malaria day 2009: what malaria knows and the immune system that immunologists still do not. J Immunol 182: 5171-5177.
6. Stevenson MM, Riley EM, (2004) Innate Immunity to malaria. Nat Rev Immunol 4: 169-180.
7. Schofield L, Grau GE, (2005) Immunological processes in malaria pathogenesis. Nat Rev Immunol 5: 722-735.
8. Hunt N, Grau GE, (2003) Cytokines: accelerators and brakes in the pathogenesis of cerebral malaria. Trends Immunol 24: 491-499.
9. Bogdan C, (2004) Relative oxygen and reactive nitrogen metabolites as effector molecules against infectious pathogens. In: Kaufmann SHE, Medzhitov R, Gordon S, editors. The Innate Immune Response to Infection ASM Press, Washington, DC pp. 357-396.
10. Kaufmann SHE, Sher A, Ahmed R, eds. (2002) Immunology of infectious diseases ASM Press, Washington, DC pp. 1-162.
11. Pearce EJ, Kane CM, Sun J, (2006) Regulation of dendritic cell function by pathogen-derived molecules plays a key role in dictating the outcomes of the adaptive immune response. Chem Immunol Allergy 90: 82-90.
12. Good MF, Xu H, Wykes M, Engwerda CR, (2005) Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu Rev Immunol 23: 69-99.
13. Wilson NS, Villadangos JA, (2005) Regulation of antigen presentation and cross-presentation in the dendritic cell network: facts, hypothesis, and immunological implications. Adv Immunol 86: 241-305.
14. Lopez-Bravo M, Ardavin C, (2008) In vivo induction of immune responses to pathogens by conventional dendritic cells. Immunity 29: 343-351.
15. Perry JA, Olver CS, Burnett RC, Avery AC, (2005) Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation. J Immunol 174: 5921-5925.
16. Steinman RM, Hemmi H, (2006) Dendritic cells: translating innate to adaptive immunity. Curr Top Microbiol Immunol 311: 17-58.
17. Manicassamy S, Pulendran B, (2009) Modulation of adaptive immunity with Toll-like receptors. Semin Immunol 21: 185-193.
18. Akira S, (2009) Innate immunity to pathogens: diversity in receptors for microbial recognition. Immunol Rev 227: 5-8.
19. Trinchieri G, Sher A, (2007) Cooperation of Toll-like receptor signals in innate immune defense. Nat Rev Immunol 7: 179-190.
20. Barton GM, Kagan JC, (2009) A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol 9: 535-542.
21. Bauer S, Muller T, Hamm S, (2009) Pattern recognition by Toll-like receptors. Adv Exp Med Biol 653: 15-34.
22. Kumar H, Kawai T, Akira S, (2009) Toll-like receptors and innate immunity. Biochem Biophys Res Commun 388: 621-625.
23. Blander JM, (2007) Coupling Toll-like receptor signaling with phagocytosis: potentiation of antigen presentation. Trends Immunol 28: 19-25.
24. Kwiatkowski D, Cannon J, Manogue K, Cerami A, Dinarello C, et al. (1989) TNF production in falciparum malaria and its association with schizoint rupture. Clin Exp Immunol 77: 361-366.
25. Kwiatkowski D, Nowak M, (1991) Periodic and chaotic host-parasite interactions in human malaria. Proc Natl Acad Sci U S A 88: 5111-5113.
26. Wu X, Gowda NM, Kumar S, Gowda DC, (2010) Protein-DNA complex is the exclusive malaria parasite component that activates dendritic cells and triggers innate immune responses. J Immunol 184: 4338-4348.
27. Mach N, Gillessen S, Wilson SB, Sheehan C, Mihm M, et al. (2000) Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res 60: 3239-3246.
28. Alkhalil A, Achur RN, Valiyaveettil M, Ockenhouse CF, Gowda DC, (2000) Structural requirements for the adherence of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate proteoglycans of human placenta. J Biol Chem 275: 40357-40364.
29. Voss TS, Mini T, Jenoe P, Beck HP, (2002) Plasmodium falciparum possesses a cell cycle-regulated short type replication protein A large subunit encoded by an unusual transcript. J Biol Chem 277: 17493-17501.
30. Schnitzler GR, (2001) Isolation of histones and nucleosome cores from mammalian cells. In: Ausubel FM, Brent G, Kingston RE, Moore DD, Smith JA, editors. Current Protocols in Molecular Biology John Wiley and Sons, New York, NY pp. 21.5.1-21.5.12.
31. Longhurst HJ, Holder AA, (1997) The histones of Plasmodium falciparum: identification, purification and a possible role in the pathology of malaria. Parasitology 114: 413-419.
32. Bachoons DS, Otero E, Hodson RE, (2001) Effects of humic substances on fluorometric DNA quantification and DNA hybridization. J Microbiol Methods 47: 73-82.
33. Stoscheck CM, (1990) Quantitation of Protein. Methods Enzymol 182: 50-69.
34. Brasel K, De Smedt T, Smith JL, Maliszewski CR, (2000) Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96: 3029-3039.
35. Zhu J, Wu X, Goel S, Gowda NM, Kumar S, et al. (2009) MAPK-activated protein kinase 2 differentially regulates Plasmodium falciparum glycosylphosphatidylinositol-induced production of tumor necrosis factor-α and interleukin-12 in macrophages. J Biol Chem 284: 15750-15761.
36. Marsh K, (1993) Immunology of human malaria, In: Gilles HM, Warrell DA, Bruce-Chwatt LJ, editors. Bruce-Chwatt's essential malariology Arnold Ltd. London pp. 60-77.
37. Langhorne J, Ndungu FM, Sponaas A-M, Marsh K, (2008) Immunity to malaria: more questions than answers. Nat Immunol 9: 725-732.
38. Carvalho LJ, Daniel-Ribeiro CT, Goto H, (2002) Malaria vaccine: candidate antigens, mechanisms, constrains and prospects. Scand J Immunol 56: 327-343.
39. Khusmith S, Druilhe P, Gentilini M, (1982) Enhanced Plasmodium falciparum merozoite phagocytosis by monocytes from immune individuals. Infect Immun 35: 874-879.
40. Barnwell JW, Galinski MR, (1998) Invasion of vertebrate cells: erythrocytes, In: Sherman IW, editors. Malaria Parasite Biology, Pathogenesis, Protection ASM Press, NY pp. 93-120.
41. Blackman MJ, (1994) Purification of Plasmodium falciparum merozoites for analysis of the processing of merozoite surface protein-1. Methods Cell Biol 45: 213-220.
42. Boyle MJ, Wilson DW, Richards JS, Riglar DT, Tetteh KK, et al. (2010) Isolation of viable Plasmodium falciparum merozoites to define erythrocyte invasion events and advance vaccine and drug development. Proc Natl Acad Sci U S A 107: 14378-14383.
43. Gilson PR, Crabb BS, (2009) Morphology and kinetics of the three distinct phases of red blood cell invasion by Plasmodium falciparum merozoites. Int J Parasitol 39: 91-96.
44. Luger K, Mäder AW, Richmond RK, Sargent DF, Richmond TJ, (1997) Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature 389: 251-260.
45. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
46. Haas T, Metzger J, Schmitz F, Heit A, Muller T, et al. (2008) The DNA sugar backbone 2′ deoxyribose determines Toll-like receptor 9 activation. Immunity 28: 315-323.
47. Parroche P, Lauw FN, Goutagny N, Latz E, Monks BG, et al. (2007) Malaria hemozoin is immunologically inert but radically enhances innate responses by presenting malaria DNA to toll-like receptor 9. Proc Natl Acad Sci U S A 104: 1919-1924.
48. Lande R, Gregorio J, Facchinetti V, Chatterjee B, Wang YH, et al. (2007) Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 449: 564-569.
49. Pichyangkul S, Yongvanitchit K, Kum-arb U, Hemmi H, Akira S, et al. (2004) Malaria blood stage parasites activate human plasmacytoid dendritic cells and murine dendritic cells through a Toll-like receptor 9-dependent pathway. J Immunol 172: 4926-4933.
50. Coban C, Ishii KJ, Kawai T, Hemmi H, Sato S, et al. (2005) Toll-like receptor 9 mediates innate immune activation by the malaria pigment hemozoin. J Exp Med 201: 19-25.
51. Foureau DM, Mielcarz DW, Menard LC, Schulthess J, Werts C, et al. (2010) TLR9-dependent induction of intestinal alpha-defensins by Toxoplasma gondii. J Immunol 184: 7022-7029.
52. Minns LA, Menard LC, Foureau DM, Darche S, Ronet C, et al. (2006) TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii. J Immunol 176: 7589-2597.
53. Bartholomeu DC, Ropert C, Melo MB, Parroche P, Junqueira CF, et al. (2008) Recruitment and endo-lysosomal activation of TLR9 in dendritic cells infected with Trypanosoma cruzi. J Immunol 181: 1333-1344.
54. de Alencar BC, Araújo AF, Penido ML, Gazzinelli RT, Rodrigues MM, (2007) Cross-priming of long lived protective CD8+ T cells against Trypanosoma cruzi infection: importance of a TLR9 agonist and CD4+ T cells. Vaccine 25: 6018-6027.
55. Bafica A, Santiago HC, Goldszmid R, Ropert C, Gazzinelli RT, et al. (2006) Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol 177: 3515-3519.
56. Abou Fakher FH, Rachinel N, Klimczak M, Louis J, Doyen N, (2009) TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions. J Immunol 182: 1386-1396.
57. Dufourcq J, Neri W, Henry-Toulme N, (1998) Molecular assembling of DNA with amphipathic peptides. FEBS Lett 421: 7-11.
58. Niidome T, Wakamatsu M, Wada A, Hirayama T, Aoyagi H, (2000) Required structure of cationic peptide for oligonucleotide-binding and-delivering into cells. J Pept Sci 6: 271-279.
59. Kubo T, Fujii M, (2001) Specific binding and stabilization of DNA and phosphorothioate DNA by amphiphilic α-helical peptides. Nucleosides Nucleotides Nucleic Acids 20: 1313-1316.
60. Sandgren S, Wittrup A, Cheng F, Jonsson M, Eklund E, et al. (2004) The human antimicrobial peptide LL-37 transfers extracellular DNA plasmid to the nuclear compartment of mammalian cells via lipid rafts and proteoglycan-dependent endocytosis. J Biol Chem 279: 17951-17956.